When combined with previous studies that demonstrated that TRAF2 plays an important role in breast cancer initiation3,6,7,29, our present findings indicate that targeting of TRAF2 may have a potential therapeutic value in halting breast cancer metastasis and protecting the skeleton from the osteolysis associated with advanced breast cancer. The gene discussed is TRAF2; the disease is breast cancer.